These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32769626)

  • 1. Time to Wake-Up: Extending the Window for Management of Unknown-Onset Strokes.
    Fawaz AM; Wu S; Viswanathan D; Kaur K; Nuoman R; Nuoaman H; Adnan YA; Gandhi CD; Kurian C; Sahni R
    Cardiol Rev; 2021; 29(1):26-32. PubMed ID: 32769626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis beyond 4.5 h in Acute Ischemic Stroke.
    Etherton MR; Gadhia RR; Schwamm LH
    Curr Neurol Neurosci Rep; 2020 Jun; 20(8):35. PubMed ID: 32607627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of intravenous thrombolytic treatment in wake-up stroke: Experiences from a single center.
    Wiśniewski A
    Brain Behav; 2021 Jun; 11(6):e02152. PubMed ID: 33939326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis for acute ischemic stroke: why not?
    Psychogios K; Tsivgoulis G
    Curr Opin Neurol; 2022 Feb; 35(1):10-17. PubMed ID: 34799512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial.
    Koga M; Toyoda K; Kimura K; Yamamoto H; Sasaki M; Hamasaki T; Kitazono T; Aoki J; Seki K; Homma K; Sato S; Minematsu K;
    Int J Stroke; 2014 Dec; 9(8):1117-24. PubMed ID: 25088843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-contrast brain ct based systemic thrombolysis of two wake up ischemic stroke patients in rural settings].
    Pozsegovits K; Rencz L; Csúsz L; Szabó G
    Ideggyogy Sz; 2017 May; 70(5-6):209-212. PubMed ID: 29870636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice: intravenous thrombolysis in a patient with active cancer who experienced wake-up stroke.
    Wu S; Xing Z; Lin J; Liu H; Cui F; Xu R
    J Int Med Res; 2021 Mar; 49(3):3000605211000155. PubMed ID: 33719669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute imaging for evidence-based treatment of ischemic stroke.
    Thomalla G; Gerloff C
    Curr Opin Neurol; 2019 Aug; 32(4):521-529. PubMed ID: 31116116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
    Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of fast MRI-based trombolysis in wake-up strokes compared to superacute ischemic strokes within 12 hours.
    Bai Q; Zhao Z; Fu P; Sui H; Xie X; Chen J; Yang J
    Neurol Res; 2013 Jun; 35(5):492-7. PubMed ID: 23601825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Treatment of Ischemic Stroke.
    Lyden S; Wold J
    Neurol Clin; 2022 Feb; 40(1):17-32. PubMed ID: 34798968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of intravenous thrombolysis for eligible patients with ischemic stroke].
    Qin HQ; Wang YJ
    Zhonghua Nei Ke Za Zhi; 2021 May; 60(5):476-482. PubMed ID: 33906280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Alteplase for Acute Ischemic Stroke in Taiwan: Can We Expand the National Health Insurance's Reimbursement Criteria?
    Hsieh CY
    Acta Neurol Taiwan; 2017 Mar; 26(1):1-2. PubMed ID: 28752507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis for acute ischemic stroke.
    Uyttenboogaart M; De Keyser J; Luijckx GJ
    Curr Top Med Chem; 2009; 9(14):1285-90. PubMed ID: 19849662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.